A New Care Model for Patients With Complicated Multimorbidity
NCT ID: NCT05406193
Last Updated: 2023-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
350 participants
INTERVENTIONAL
2022-11-01
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced Care for Patients With Complex Multimorbidity in Primary Care
NCT05676541
Implementation of Community-based Collaborative Management of Complex Chronic Patients
NCT02956395
Feasibility and Acceptability of a Complex Intervention to Improve Initial Medication Adherence
NCT05094986
Establish an Evaluation Scale for the Quality of Primary Care in Multi-professional Health Centres and Homes Integrating the Point of View of Patients in Complex Care Situations and Their Caregivers.
NCT05057520
Impact of a Health Intervention on Some Indicators in the Care of Chronic Complex Patient (CCP).
NCT03091036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention (CIM2)
An extended overview consultation, lasting 45 minutes, with the general practitioner, the patient (and maybe a relative), and the care coordinator. An individual care plan is developed, covering planned activities in the three sectors (general practice, municipality, and hospital) that will take place within the 12-month intervention period. General practice coordinates the planned patient care between general practice, the municipality, and the hospital, and follow-up on the execution of planned healthcare activities. The individual care plan is shared electronically with the healthcare center in the municipality and with the outpatient clinics using the standard IT-communication tool provided by MedCom and a routinely used national standard in general practice, hospitals, and municipalities.
Patient-centred complex intervention in complicated multimorbidity (CIM2)
CIM2 is the second version of the Patient-centred complex intervention in complicated multimorbidity
Usual care
Patients with a general practitioner allocated to the control group will receive usual care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient-centred complex intervention in complicated multimorbidity (CIM2)
CIM2 is the second version of the Patient-centred complex intervention in complicated multimorbidity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Has been hospitalised, or visited an outpatient clinic due to their chronic diseases during the previous year
3. Take at least five different prescription drugs assessed from the Shared Medicine Card recording in the general practice
4. The general practitioner or the nurse in the practice recognise the patient as a "demanding" patient with complicated multimorbidity that will benefit from an overview consultation.
Exclusion Criteria
* Patients who cannot give informed consent,
* Patients who have a life expectancy of less than 12 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Slagelse Hospital
OTHER
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Frølich, Professor
Role: STUDY_CHAIR
Innovation and Research Centre for Multimorbidity, Slagelse hospital, Region Zealand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lægerne Kanaltorvet
Albertslund, , Denmark
Thorkil Christensen
Albertslund, , Denmark
Brøndbyøster Torv
Brøndby, , Denmark
Lægerne i Brohuset
Ishøj, , Denmark
Lægecenter Korsør
Korsør, , Denmark
Læge Depenau vej-Hansen
Slagelse, , Denmark
Læge Jørgen Larsen
Slagelse, , Denmark
Læge Lene Stiggaard
Slagelse, , Denmark
Lægerne Reventlow, Wolfhagen og Bendtsen
Slagelse, , Denmark
Lægerne ved Lystskoven
Slagelse, , Denmark
Lægerne Vallensbæk Nord
Vallensbæk, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lene Stiggaard, GP
Role: primary
Johan Reventlow, GP
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lundstrom SL, Kamstrup-Larsen N, Barrett BA, Jorgensen LMB, Hansen SS, Andersen JS, Friderichsen B, Stockmarr A, Frolich A. A patient-centred care model for patients with complicated multimorbidity: Protocol for a pilot cluster randomised trial in general practice, municipalities, and hospitals. PLoS One. 2024 Dec 4;19(12):e0310697. doi: 10.1371/journal.pone.0310697. eCollection 2024.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MM14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.